Call | Career Development Fellowship (CDF) |
Programme | EDCTP2 |
Start Date | 2019-09-01 |
End Date | 2023-01-31 |
Project Code | TMA2018CDF-2397 |
Status | Active |
Operational feasibility, impact of additional screening using highly-sensitives Rapid Diagnostic Tests combined with high coverage of IPTp-SP on placental malaria and low birth weight (ASSER Malaria)
1. To determine the gain of additional screening with HS-RDTs and treatment with DP against placental malaria, LBW and peripheral malaria infection at delivery 2.To assess the determinants of the poor coverage and improve the number of IPTp doses received using phone call or SMS as a reminder
Institution | Country |
---|---|
Centre National de la Recherche Scientifique et Technologique (CNRST) - Institut de Recherche en Science de la Santé (IRSS) | Burkina Faso |
This study is a phase III, 2-arms randomized open trial with a nested study study (qualitative social behavioral study) to be carried out in Nanoro district.
Sanitary District of Nanoro |
Type | Name | Title | University | Start Date | End Date |
---|---|---|---|---|---|
Medical Doctor | Sanou Hyacinthe | Evaluation de la performance du Test de Diagnostic Rapide AlereTM Malaria Ag Pf ultrasensible pour le diagnostic du paludisme chez la femme enceinte en zone de haute transmission : Cas du district sanitaire de Nanoro au Burkina Faso | University Joseph Ki Zerbo | 2020 | 2021 |
Medical Doctor | Miningou P. Aristide | Bactériémies dans le District Sanitaire de Nanoro: Pathogènes principaux et profil de sensibilité aux antibiotiques | University Joseph Ki Zerbo | 2020 | 2021 |
Doctor in Pharmacy | Sougue Melika | Profil épidémiologique du paludisme à P falciparum chez la femme enceinte lors de la première consultation prénatale et facteurs de risque associés | University Joseph Ki Zerbo | 2021 | 2022 |
Doctor in Pharmacy | Zoma Nadège | Séroprévalence de la toxoplasmose chez les femmes enceintes et facteurs de risques associés en milieu rural au Burkina Faso : cas du district sanitaire de Nanoro | University Joseph Ki Zerbo | 2021 | 2022 |
Master in Epidemiology | Lougue Medina | Performance du test de diagnostic rapide ultrasensible AlereTM Malaria Plasmodium falciparum chez la femme enceinte au cours de la première consultation prénatale dans le district sanitaire de Nanoro | University Joseph Ki Zerbo | 2021 | 2022 |
Master In Socio-anthropology | Ouedraogo Kadija | Factors affecting pregnant women's adherence to intermittent preventive treatment of malaria in the Nanoro health district | Université Catholique de l'Afrique de l'Ouest | 2021 | 2022 |
Clinical Research Unit of Nanoro/IRSS-DRCO/CNRST
Research Associate
2020 | Small Grant Foundation Mérieux (Malaria in Pregnancy at first ANC) |
Type | Name | Title | University | Start Date | End Date |
---|---|---|---|---|---|
Medical Doctor | Sanou Hyacinthe | Université Ouaga 1 Joseph Ki-Zerbo | 2020 |
Institution | Degree | Year |
---|---|---|
University of Ouaga 1, Burkina Faso | Doctor in Pharmacy | 2005-06-30 |
Polytechnic University of Bobo, Burkina Faso | Master in Applied Biology and Modelling of Biological Systems | 2008-06-30 |
University of Antwerp, Belgium | PhD in Medical Sciences | 2017-05-09 |
UKAS, United Kingdom | Auditor ISO 15189 | 2020-09-17 |
Fondation Mérieux, France | Expert in Clinical Lab Quality Management | 2021-02-09 |
Malaria Neglected Infectious Diseases (NID) Lower Respiratory Tract Infections (LRTIs) Diarrhoeal Diseases (DDs)
Background: Malaria infection during pregnancy (MIP) is not only deleterious to the woman, but it also puts her fetus at increased risk of adverse outcomes, such as preterm delivery, low birth weight, and intrauterine growth retardation. Additionally, all-cause mortality during the first year of life in babies born to women with malaria during pregnancy is also increased. Many interventions such as IPTp-SP and long-lasting insecticidal nets have proven to be efficient at reducing malaria in pregnancy burden but adherence to recommended policies remains poor. In sub- Saharan Africa, malaria in pregnancy is often asymptomatic and many malaria infections may be missed due to the inadequate performance of the current rapid diagnostic test to detect low-level parasitemias. Therefore, additional strategies such as intermittent screening with ultrasensitive rapid diagnostic tests and treatment with an effective artemisinin-based combination therapy in addition to IPTp-SP could reduce placental malaria, peripheral malaria infection at delivery, and low birth weight.
Methods: This pilot 2-group randomized open trial with a nested qualitative social behavioral will be carried out
in Nanoro district in which 340 pregnant women will be recruited. Pregnant women will be randomized into two groups and followed on a monthly basis until delivery. In the intervention group, monthly screening using ultrasensi- tive rapid diagnostic tests and treatment of those found to be infected with dihydroartemisinin-piperaquine will be performed. In addition, a reminder will be sent to increase the uptake of IPTp-SP doses per woman. During scheduled and unscheduled visits, malaria infection, hemoglobin level, and other clinical outcomes will be assessed and com- pared by the group. The primary feasibility outcome will evaluate the study site’s capacity to enroll participants and
the women’s perception and acceptability of the intervention. The primary clinical outcome will be the prevalence of placental malaria at delivery.
Discussion: The present protocol aims to evaluate the feasibility on a large-scale and also to demonstrate the impact and the operational feasibility of additional screening with ultrasensitive rapid diagnostic tests and treatment with DHA-PQ on placental malaria, low birth weight, and peripheral malaria infection at delivery in a high-burden setting in Burkina Faso.
Trial registration: ClinicalTrials.gov, ID: NCT04147546 (14 October 2019).
Keywords: Malaria in pregnancy, IPTp, Intermittent screening and treatment, Ultrasensitive RDTs, Placental malaria
Name | Country | Institution |
---|---|---|
Roger Tine | Senegal | UCAD |